OncoVista Innovative Therapies, Inc.

Share · US68232J1051 (OTC)

Overview

No Price

Closing Price OTC 08.12.2025: 0,0001 USD

08.12.2025 21:00

Current Prices from OncoVista Innovative Therapies, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	OVIT	USD	08.12.2025 21:00	0,0001 USD	0,00 USD

Company Profile for OncoVista Innovative Therapies, Inc. Share

OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.

Get up to date insights from finAgent about OncoVista Innovative Therapies, Inc.

Company Data

Name OncoVista Innovative Therapies, Inc.

Company OncoVista Innovative Therapies, Inc.

Website https://www.oncovista.com

Primary Exchange

UTC

ISIN US68232J1051

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Alexander L. Weis

Country United States of America

Currency USD

Employees 0,0 T

Address 14785 Omicron Drive, 78245 San Antonio

IPO Date 2007-10-26

Ticker Symbols

Name	Symbol
Over The Counter	OVIT

More Shares

Investors who hold OncoVista Innovative Therapies, Inc. also have the following shares in their portfolio:

C-QUA.AC.ETF SEL.EO P1(T) Fund

Galata Acquisition Corp. II - Class A Ordinary Shares Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog